RE:RE:RE:RE:RE:FYIold_dog wrote: This just goes to show or highlight how slow everything is moving. So some folks think VPT is going to be sitting by the phones taking call after call. Not to say that things aren't moving but the medical world has come to a somewhat grinding halt in a lot of ways. Now I do expect that we should have some sort of news by Mid January as I have stated, I figure something has to be coming down the tube by then.
Now that the medical community is aware of the heart issue problem with Covid I suspect this will start to drive the stock. There is an old saying...Time is Tissue...so the longer you spend dealing with a heart issue the more damage that occurs
in the mean time if any one wants to have some daily fun...go to "world of meters" Covid , and look for this number in the death row...4634....That country has not had a single death in 5-7 months...and they only report 25 case a day.....But yet this is a country that says everything is normal.
old_dog
Delay in adoption of new technologies, is definitely something that is recognized in medicine.
Regarding artificial intelligence, there was an interesting article I came about when I was doing some research over the holidays, that specifically was a guide for medical professions about the promise and perils of artificial intelligence. The comment that you made , does align with this article as noted here:
“They first made an FDA-approved smartphone case that worked as a single lead ECG in 2012. They launched two clinical trials to test the hardware and the app comparing it to a traditional 12-lead device. Later, the evolution of its design resulted in a credit-card sized device and an even smaller version in 2019. The original device could provide a one channel ECG by playing the user’s fingertips on the sensor for 30 s. The results were uploaded to the cloud to make it accessible for physicians. In 2015, Alivecor received clearance by the FDA to use an algorithm for the analysis of the readings to determine issues related to heart rhythm without human help.
By the end of 2017, they already used deep learning networks, and the FDA cleared the company’s ECG reader called KardiaBand as a medical device accessory to the Apple Watch. A study concluded that the device managed to distinguish between atrial fibrillation and a normal heart rhythm with a sensitivity of 93, and a specificity of 94%, respectively. Its sensitivity increased to 99% when a medical professional reviewed the reading26.
By 2020, products of Alivecor have been tested in over 40 clinical studies. Despite these accomplishments, the use of the device is still not common practice. And as other companies producing A.I.-based medical technologies are lagging behind, it might depict a long period of adoption.
A.I. will only reach the status of an everyday medical technology if medical associations provide clear guidelines about implementing it; if policy makers create policies that favor adoption; and if the medical community does not look at A.I. as a threat, but rather, as the stethoscope of the 21st century.”
https://www.nature.com/articles/s41746-020-00333-z I guess the question is, how long does it take to adopt? The technology has been around for VPT for around 10 years, and wondering if we have a number of installed programs and paying customers to date?
The other questi0on relates to competition. We see here the EKG as AI-what about cardiac ultrasound?